StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$305.19+0.13 (+0.04%)

Close on Nov 18, 2026Market cap $8.52BP/E –Yield –

Praxis Precision Medicines revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Praxis Precision Medicines's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$8.55M+249.5%
FY2023Dec 31, 2023$2.45M–
FY2022Dec 31, 2022$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$7.46M+1349.1%
Q3 FY2024Sep 30, 2024$302.00K-35.5%
Q2 FY2024Jun 30, 2024$357.00K-54.3%
Q1 FY2024Mar 31, 2024$431.00K-36.9%
Q4 FY2023Dec 31, 2023$515.00K–
Q3 FY2023Sep 30, 2023$468.00K–
Q2 FY2023Jun 30, 2023$781.00K–
Q1 FY2023Mar 31, 2023$683.00K–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–

More Praxis Precision Medicines figures

See a number that looks wrong?